Inas A. Ruhban

752 total citations
7 papers, 244 citations indexed

About

Inas A. Ruhban is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Inas A. Ruhban has authored 7 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Inas A. Ruhban's work include Multiple and Secondary Primary Cancers (4 papers), Global Cancer Incidence and Screening (3 papers) and Colorectal Cancer Screening and Detection (2 papers). Inas A. Ruhban is often cited by papers focused on Multiple and Secondary Primary Cancers (4 papers), Global Cancer Incidence and Screening (3 papers) and Colorectal Cancer Screening and Detection (2 papers). Inas A. Ruhban collaborates with scholars based in United States, Syria and Egypt. Inas A. Ruhban's co-authors include Mohamed M. Gad, Muneer J. Al‐Husseini, Anas M. Saad, Mohamad Bassam Sonbol, Thai H. Ho, Khalid Jazieh, Mohammed Faisaluddin, C. Roberto Simons-Linares, Bassam Estfan and Mihnea‐Alexandru Găman and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Oncologist.

In The Last Decade

Inas A. Ruhban

7 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inas A. Ruhban United States 4 156 104 98 77 32 7 244
Chaiyut Charoentum Thailand 7 128 0.8× 146 1.4× 144 1.5× 32 0.4× 20 0.6× 30 244
Harsh Dhar India 9 65 0.4× 98 0.9× 69 0.7× 48 0.6× 25 0.8× 24 256
Teresa Bonfill Spain 9 81 0.5× 72 0.7× 99 1.0× 33 0.4× 26 0.8× 35 221
Jacques Irani France 8 216 1.4× 75 0.7× 39 0.4× 62 0.8× 67 2.1× 12 338
Mark Jalkut United States 6 239 1.5× 45 0.4× 55 0.6× 137 1.8× 96 3.0× 9 316
Tuukka Mäkinen Finland 8 245 1.6× 56 0.5× 129 1.3× 21 0.3× 19 0.6× 9 283
Faruk Özcan Türkiye 11 133 0.9× 148 1.4× 43 0.4× 96 1.2× 27 0.8× 39 308
Haowen Jiang China 12 220 1.4× 29 0.3× 92 0.9× 55 0.7× 57 1.8× 20 303
W. Edward Fiets Netherlands 5 90 0.6× 95 0.9× 63 0.6× 18 0.2× 60 1.9× 16 206
Martín Lázaro-Quintela Spain 9 84 0.5× 30 0.3× 89 0.9× 42 0.5× 22 0.7× 20 170

Countries citing papers authored by Inas A. Ruhban

Since Specialization
Citations

This map shows the geographic impact of Inas A. Ruhban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inas A. Ruhban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inas A. Ruhban more than expected).

Fields of papers citing papers by Inas A. Ruhban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inas A. Ruhban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inas A. Ruhban. The network helps show where Inas A. Ruhban may publish in the future.

Co-authorship network of co-authors of Inas A. Ruhban

This figure shows the co-authorship network connecting the top 25 collaborators of Inas A. Ruhban. A scholar is included among the top collaborators of Inas A. Ruhban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inas A. Ruhban. Inas A. Ruhban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Afifi, Ahmed, Ahmed O. Elmehrath, Inas A. Ruhban, et al.. (2021). Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.: A Population-Based Analysis. The Oncologist. 26(9). 733–739. 17 indexed citations
2.
Gad, Mohamed M., Anas M. Saad, Mohammed Faisaluddin, et al.. (2020). Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends. Clinics and Research in Hepatology and Gastroenterology. 44(6). 885–893. 63 indexed citations
3.
Ruhban, Inas A., et al.. (2019). Racial disparities in lung cancer incidence and mortality over the last two decades; a Population-Based Study. Annals of Oncology. 30. vi107–vi107. 1 indexed citations
4.
Saad, Anas M., Mohamed M. Gad, Muneer J. Al‐Husseini, et al.. (2018). Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study. Clinical Genitourinary Cancer. 17(1). 46–57.e5. 144 indexed citations
5.
Al‐Husseini, Muneer J., Anas M. Saad, Khalid Jazieh, et al.. (2018). Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups. International Journal of Colorectal Disease. 34(2). 285–292. 16 indexed citations
6.
Gad, Mohamed M., et al.. (2018). Incidence and mortality of renal cell carcinoma in the U.S.: A SEER-based study investigating trends over the last four decades.. Journal of Clinical Oncology. 36(6_suppl). 604–604. 2 indexed citations
7.
Saad, Anas M., et al.. (2018). The risk of developing hepatocellular carcinoma following non-Hodgkin lymphoma.. Journal of Clinical Oncology. 36(15_suppl). e16141–e16141. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026